CCM
AGL icon

CAAS Capital Management’s Agilon Health AGL Stock Holding History

CAAS Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-480
Closed -$151K – 507
2023
Q4 		$151K Buy
+480
New +$174K 0.02% 368
2021
Q4 		– Sell
-5,730
Closed -$3.75M – 852
2021
Q3 		$3.75M Sell
5,730
-5,326
-48% -$4.55M 0.08% 250
2021
Q2 		$11.2M Buy
+11,056
New +$9.69M 0.19% 127

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAAS Capital Management's AGL Position: Q1 2024 in Review

CAAS Capital Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 480 shares — an estimated $151K sold.

CAAS Capital Management first reported a position in AGL in Q2 2021 and held it in 3 quarters. The position peaked at $11.2M in Q2 2021. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • CAAS Capital Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • CAAS Capital Management sold 480 Agilon Health shares in Q1 2024, an estimated $151K.
  • CAAS Capital Management first reported a position in Agilon Health in Q2 2021 and held it in 3 quarters.
  • CAAS Capital Management's Agilon Health position peaked at $11.2M in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on CAAS Capital Management's 13F filing for Q1 2024, filed 26 Apr 2024.